Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,440 | -21,546 | -10,196 | -58,769 | -47,141 |
| Depreciation Amortization | -80 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | 206 | N/A |
| Accounts payable and accrued liabilities | -543 | 2,508 | 1,086 | -28,862 | -679 |
| Other Working Capital | 557 | 566 | 2,346 | -25,305 | -1,063 |
| Other Operating Activity | 2,193 | -1,508 | -677 | 45,025 | 36,064 |
| Operating Cash Flow | $-31,313 | $-19,980 | $-7,441 | $-67,705 | $-12,819 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,523 | N/A | N/A | 95,000 | N/A |
| PPE Investments | -183 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-34,706 | $N/A | $N/A | $95,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,500 | 7,500 | 7,500 | N/A | 9,993 |
| Common Stock Issued | N/A | N/A | N/A | 21 | 1 |
| Other Financing Activity | 99,767 | 99,767 | 99,767 | 0 | 1,569 |
| Financing Cash Flow | $107,267 | $107,267 | $107,267 | $21 | $11,563 |
| Beginning Cash Position | 1,639 | 1,639 | 1,639 | 90,973 | 3,169 |
| End Cash Position | 42,887 | 88,926 | 101,465 | 118,289 | 1,913 |
| Net Cash Flow | $41,248 | $87,287 | $99,826 | $27,316 | $-1,256 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,313 | -19,980 | -7,441 | -67,705 | -12,819 |
| Capital Expenditure | -183 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -31,496 | -19,980 | -7,441 | -67,705 | -12,819 |